Royal Harbor Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$426K Hold
463
0.14% 39
2025
Q4
$498K Sell
463
-70
-13% -$66.9K 0.16% 36
2025
Q3
$407K Buy
533
+2
+0.4% +$1.49K 0.14% 35
2025
Q2
$414K Hold
531
0.15% 36
2025
Q1
$439K Hold
531
0.17% 34
2024
Q4
$410K Buy
531
+1
+0.2% +$828 0.15% 33
2024
Q3
$470K Hold
530
0.18% 33
2024
Q2
$480K Buy
+530
New +$424K 0.2% 31
2023
Q3
Sell
-888
Closed -$416K 61
2023
Q2
$416K Hold
888
0.2% 56
2023
Q1
$305K Sell
888
-3,736
-81% -$1.26M 0.16% 65
2022
Q4
$1.69M Sell
4,624
-381
-8% -$135K 1.05% 31
2022
Q3
$1.62M Sell
5,005
-1,426
-22% -$452K 1.11% 32
2022
Q2
$2.08M Buy
6,431
+52
+0.8% +$15.6K 1.42% 30
2022
Q1
$1.83M Sell
6,379
-219
-3% -$56.4K 1.17% 23
2021
Q4
$1.82M Buy
6,598
+192
+3% +$48.7K 1.16% 20
2021
Q3
$1.48M Sell
6,406
-784
-11% -$194K 1.05% 25
2021
Q2
$1.65M Sell
7,190
-578
-7% -$116K 1.1% 22
2021
Q1
$1.45M Sell
7,768
-415
-5% -$81.2K 1.11% 22
2020
Q4
$1.38M Buy
8,183
+2,117
+35% +$316K 1.16% 17
2020
Q3
$898K Buy
6,066
+141
+2% +$21.8K 0.84% 28
2020
Q2
$973K Buy
+5,925
New +$909K 0.96% 21

Other funds holding LLY

Royal Harbor Partners's LLY Position: Q1 2026 in Review

Royal Harbor Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 463 shares worth $426K. The position accounts for 0.14% of the portfolio, ranked #39.

Royal Harbor Partners first reported a position in LLY in Q2 2020 and has held it in 21 quarters since. The position peaked at $2.08M in Q2 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Royal Harbor Partners held 463 shares of Eli Lilly worth $426K as of Q1 2026.
  • Royal Harbor Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.14% of Royal Harbor Partners's portfolio in Q1 2026, its #39 holding.
  • Royal Harbor Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 21 quarters since.
  • Royal Harbor Partners's Eli Lilly position peaked at $2.08M in Q2 2022.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Royal Harbor Partners's 13F filing for Q1 2026, filed 24 Apr 2026.